Caitlin Kontulis
Director Financiero/CFO en PHIO PHARMACEUTICALS CORP. .
Fortuna: 7 514 $ al 30/04/2024
Perfil
Caitlin Kontulis is currently working as the Secretary, VP-Finance & Administration at Phio Pharmaceuticals Corp.
Previously, she worked as the Interim Chief Accounting Officer at Galena Biopharma, Inc. She completed her graduate degree from Northeastern University in 2008 and her undergraduate degree from Bryant University in 2007.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
01/03/2024 | 10 643 ( 0.23% ) | 7 514 $ | 30/04/2024 |
Cargos activos de Caitlin Kontulis
Empresas | Cargo | Inicio |
---|---|---|
PHIO PHARMACEUTICALS CORP. | Director Financiero/CFO | - |
Antiguos cargos conocidos de Caitlin Kontulis.
Empresas | Cargo | Fin |
---|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | - |
Formación de Caitlin Kontulis.
Bryant University | Undergraduate Degree |
Northeastern University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PHIO PHARMACEUTICALS CORP. | Health Technology |
Empresas privadas | 1 |
---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Caitlin Kontulis